Kebotix Revenue and Competitors

Boston, MA USA

Location

$16.4M

Total Funding

Chemicals

Industry

Estimated Revenue & Valuation

  • Kebotix's estimated annual revenue is currently $3.5M per year.(i)
  • Kebotix's estimated revenue per employee is $291,667
  • Kebotix's total funding is $16.4M.

Employee Data

  • Kebotix has 12 Employees.(i)
  • Kebotix grew their employee count by 0% last year.

Kebotix's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP Business Development and PartnershipsReveal Email/Phone
3
Chief Operating OfficerReveal Email/Phone
4
Chief Technology OfficerReveal Email/Phone
5
Professor Chief Visionary OfficerReveal Email/Phone
6
Machine Learning ScientistReveal Email/Phone
7
VariousReveal Email/Phone
8
Machine Learning ScientistReveal Email/Phone
9
Machine Learning ChemistReveal Email/Phone
10
ChairmanReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$35M709%N/AN/A
#2
$3.5M120%$16.4MN/A
#3
N/A330%N/AN/A
#4
N/A50%N/AN/A
#5
$7.5M22088%N/AN/A
#6
$3.5M33-3%N/AN/A
#7
$3.5M425%N/AN/A
#8
N/A11-15%N/AN/A
#9
$35M260%N/AN/A
#10
N/A41-5%N/AN/A
Add Company

What Is Kebotix?

Kebotix is a technology company ushering in the future of new materials discovery. Developing the world’s first self-driving lab for materials discovery powered by AI and robotics, Kebotix is committed to accelerating the exploration, discovery, applications and production of new molecules and materials.

keywords:N/A

$16.4M

Total Funding

12

Number of Employees

$3.5M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Kebotix News

2021-08-10 - MIT's Connor Coley Joins Kebotix Advisory Panel

CAMBRIDGE, Mass., Aug. 10, 2021 /PRNewswire/ -- Connor Coley, who joined MIT's Department of Chemical Engineering as an assistant professor one year after being named to Forbes' "30 under 30" list for healthcare, is the latest member of Kebotix's advisory panel. Kebotix, a U.S.-based technolo ...

2020-08-17 - Kebotix Raises Investment from ArcTern Ventures

Kebotix, a Cambridge-based technology platform company for new chemicals and materials, announced ArcTern Ventures as a major investor in its Series A funding that raised $11.4m. The funding, announced in the spring, was led by Denmark-based Novo Holdings. ArcTern, which joins One Way Ventures ...

2020-08-14 - Kebotix Raise $11.4 million In Series A

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Kebotix, a Cambridge-based technology platform company for new chemicals and materials, announced ArcTern Ventures as a major investor in its Series A funding that raised $11.4 million. The funding, announced in the spring, was led by Denmark-based Novo Holding ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A129%N/A
#2
$1.5M120%N/A
#3
$1.8M12-43%N/A
#4
$1.3M12-8%N/A
#5
N/A1220%N/A